Liposomal Bupivacaine Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type ( 20ml, 10ml ); Application ( Veterinary, Human )

Report Code: TIPRE00022324 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!
MARKET INTRODUCTION

Liposomal bupivacaine (Exparel) is a long-acting anaesthetic injected inside the area to provide long-term pain relief after a surgical procedure. An immediate-release HCl bupivacaine injection is effective for acute surgical pain; however, Exparel has the added advantage of being a longer-acting injection form that can be used to treat acute surgical pain.

MARKET SCOPE

The "Global Liposomal Bupivacaine Market Analysis to 2028" is a specialized and in-depth study of the food and beverages industry with a special focus on the global market trend analysis. The report aims to provide an overview of the Liposomal Bupivacaine market with detailed market segmentation by type, end use, and geography. The report provides key statistics on the market status of the leading Liposomal Bupivacaine market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION
  •   Based on type, the global Liposomal Bupivacaine market is segmented into 20ml, 10ml.
  •   On the basis of end use, the market is segmented into Veterinary, Human.
MARKET DYNAMICS

Drivers-
  •   With increasing cases of obesity all over the globe
  •   Increasing binge eating and consumption of junk foods, neglect towards regular exercise, rising levels of stress
Restraints-
  •   High cost of drug
REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The Liposomal Bupivacaine market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the marketduring the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the Liposomal Bupivacaine market in these regions.

IMPACT OF COVID-19 ON LIPOSOMAL BUPIVACAINE MARKET

Several treatment regimens are being tested around the world in an attempt to find a safe solution for Covid-19. One treatment choice is to use hydroxychloroquine, and another is to use antiviral drugs used in HIV disease management. Many of these tactics increased demand for modern antivirals and antimalarial drugs. This has consequences for pharmaceutical companies since an off-label indication for these drug classes must be created. For the time being, the WHO has not prescribed any of these approaches and has made no determination as to which is superior.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the Liposomal Bupivacaine market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from Liposomal Bupivacaine market are anticipated to lucrative growth opportunities in the future with the rising demand for Liposomal Bupivacaine in the global market.

The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the Liposomal Bupivacaine market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.
  •   Sun Pharmaceutical Industries Ltd.
  •   Johnson and Johnson
  •   Merck and Co.
  •   Cipla, Inc.
  •   Cadila Pharmaceuticals
  •   SRS Pharmaceuticals Pvt. Ltd.
  •   EXPAREL
  •   Pacira
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Liposomal Bupivacaine Market - By Type
1.3.2 Liposomal Bupivacaine Market - By Application
1.3.3 Liposomal Bupivacaine Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. LIPOSOMAL BUPIVACAINE MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. LIPOSOMAL BUPIVACAINE MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. LIPOSOMAL BUPIVACAINE MARKET - GLOBAL MARKET ANALYSIS
6.1. LIPOSOMAL BUPIVACAINE - GLOBAL MARKET OVERVIEW
6.2. LIPOSOMAL BUPIVACAINE - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING
7. LIPOSOMAL BUPIVACAINE MARKET - REVENUE AND FORECASTS TO 2028 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. 20ML
7.3.1. Overview
7.3.2. 20ml Market Forecast and Analysis
7.4. 10ML
7.4.1. Overview
7.4.2. 10ml Market Forecast and Analysis
8. LIPOSOMAL BUPIVACAINE MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. VETERINARY
8.3.1. Overview
8.3.2. Veterinary Market Forecast and Analysis
8.4. HUMAN
8.4.1. Overview
8.4.2. Human Market Forecast and Analysis
9. LIPOSOMAL BUPIVACAINE MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Liposomal Bupivacaine Market Overview
9.1.2 North America Liposomal Bupivacaine Market Forecasts and Analysis
9.1.3 North America Liposomal Bupivacaine Market Forecasts and Analysis - By Type
9.1.4 North America Liposomal Bupivacaine Market Forecasts and Analysis - By Application
9.1.5 North America Liposomal Bupivacaine Market Forecasts and Analysis - By Countries
9.1.5.1 United States Liposomal Bupivacaine Market
9.1.5.1.1 United States Liposomal Bupivacaine Market by Type
9.1.5.1.2 United States Liposomal Bupivacaine Market by Application
9.1.5.2 Canada Liposomal Bupivacaine Market
9.1.5.2.1 Canada Liposomal Bupivacaine Market by Type
9.1.5.2.2 Canada Liposomal Bupivacaine Market by Application
9.1.5.3 Mexico Liposomal Bupivacaine Market
9.1.5.3.1 Mexico Liposomal Bupivacaine Market by Type
9.1.5.3.2 Mexico Liposomal Bupivacaine Market by Application
9.2. EUROPE
9.2.1 Europe Liposomal Bupivacaine Market Overview
9.2.2 Europe Liposomal Bupivacaine Market Forecasts and Analysis
9.2.3 Europe Liposomal Bupivacaine Market Forecasts and Analysis - By Type
9.2.4 Europe Liposomal Bupivacaine Market Forecasts and Analysis - By Application
9.2.5 Europe Liposomal Bupivacaine Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Liposomal Bupivacaine Market
9.2.5.1.1 Germany Liposomal Bupivacaine Market by Type
9.2.5.1.2 Germany Liposomal Bupivacaine Market by Application
9.2.5.2 France Liposomal Bupivacaine Market
9.2.5.2.1 France Liposomal Bupivacaine Market by Type
9.2.5.2.2 France Liposomal Bupivacaine Market by Application
9.2.5.3 Italy Liposomal Bupivacaine Market
9.2.5.3.1 Italy Liposomal Bupivacaine Market by Type
9.2.5.3.2 Italy Liposomal Bupivacaine Market by Application
9.2.5.4 Spain Liposomal Bupivacaine Market
9.2.5.4.1 Spain Liposomal Bupivacaine Market by Type
9.2.5.4.2 Spain Liposomal Bupivacaine Market by Application
9.2.5.5 United Kingdom Liposomal Bupivacaine Market
9.2.5.5.1 United Kingdom Liposomal Bupivacaine Market by Type
9.2.5.5.2 United Kingdom Liposomal Bupivacaine Market by Application
9.2.5.6 Rest of Europe Liposomal Bupivacaine Market
9.2.5.6.1 Rest of Europe Liposomal Bupivacaine Market by Type
9.2.5.6.2 Rest of Europe Liposomal Bupivacaine Market by Application
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Liposomal Bupivacaine Market Overview
9.3.2 Asia-Pacific Liposomal Bupivacaine Market Forecasts and Analysis
9.3.3 Asia-Pacific Liposomal Bupivacaine Market Forecasts and Analysis - By Type
9.3.4 Asia-Pacific Liposomal Bupivacaine Market Forecasts and Analysis - By Application
9.3.5 Asia-Pacific Liposomal Bupivacaine Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Liposomal Bupivacaine Market
9.3.5.1.1 Australia Liposomal Bupivacaine Market by Type
9.3.5.1.2 Australia Liposomal Bupivacaine Market by Application
9.3.5.2 China Liposomal Bupivacaine Market
9.3.5.2.1 China Liposomal Bupivacaine Market by Type
9.3.5.2.2 China Liposomal Bupivacaine Market by Application
9.3.5.3 India Liposomal Bupivacaine Market
9.3.5.3.1 India Liposomal Bupivacaine Market by Type
9.3.5.3.2 India Liposomal Bupivacaine Market by Application
9.3.5.4 Japan Liposomal Bupivacaine Market
9.3.5.4.1 Japan Liposomal Bupivacaine Market by Type
9.3.5.4.2 Japan Liposomal Bupivacaine Market by Application
9.3.5.5 South Korea Liposomal Bupivacaine Market
9.3.5.5.1 South Korea Liposomal Bupivacaine Market by Type
9.3.5.5.2 South Korea Liposomal Bupivacaine Market by Application
9.3.5.6 Rest of Asia-Pacific Liposomal Bupivacaine Market
9.3.5.6.1 Rest of Asia-Pacific Liposomal Bupivacaine Market by Type
9.3.5.6.2 Rest of Asia-Pacific Liposomal Bupivacaine Market by Application
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Liposomal Bupivacaine Market Overview
9.4.2 Middle East and Africa Liposomal Bupivacaine Market Forecasts and Analysis
9.4.3 Middle East and Africa Liposomal Bupivacaine Market Forecasts and Analysis - By Type
9.4.4 Middle East and Africa Liposomal Bupivacaine Market Forecasts and Analysis - By Application
9.4.5 Middle East and Africa Liposomal Bupivacaine Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Liposomal Bupivacaine Market
9.4.5.1.1 South Africa Liposomal Bupivacaine Market by Type
9.4.5.1.2 South Africa Liposomal Bupivacaine Market by Application
9.4.5.2 Saudi Arabia Liposomal Bupivacaine Market
9.4.5.2.1 Saudi Arabia Liposomal Bupivacaine Market by Type
9.4.5.2.2 Saudi Arabia Liposomal Bupivacaine Market by Application
9.4.5.3 U.A.E Liposomal Bupivacaine Market
9.4.5.3.1 U.A.E Liposomal Bupivacaine Market by Type
9.4.5.3.2 U.A.E Liposomal Bupivacaine Market by Application
9.4.5.4 Rest of Middle East and Africa Liposomal Bupivacaine Market
9.4.5.4.1 Rest of Middle East and Africa Liposomal Bupivacaine Market by Type
9.4.5.4.2 Rest of Middle East and Africa Liposomal Bupivacaine Market by Application
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Liposomal Bupivacaine Market Overview
9.5.2 South and Central America Liposomal Bupivacaine Market Forecasts and Analysis
9.5.3 South and Central America Liposomal Bupivacaine Market Forecasts and Analysis - By Type
9.5.4 South and Central America Liposomal Bupivacaine Market Forecasts and Analysis - By Application
9.5.5 South and Central America Liposomal Bupivacaine Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Liposomal Bupivacaine Market
9.5.5.1.1 Brazil Liposomal Bupivacaine Market by Type
9.5.5.1.2 Brazil Liposomal Bupivacaine Market by Application
9.5.5.2 Argentina Liposomal Bupivacaine Market
9.5.5.2.1 Argentina Liposomal Bupivacaine Market by Type
9.5.5.2.2 Argentina Liposomal Bupivacaine Market by Application
9.5.5.3 Rest of South and Central America Liposomal Bupivacaine Market
9.5.5.3.1 Rest of South and Central America Liposomal Bupivacaine Market by Type
9.5.5.3.2 Rest of South and Central America Liposomal Bupivacaine Market by Application
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL LIPOSOMAL BUPIVACAINE MARKET
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Middle East and Africa
10.5 South and Central America
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOINT VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. LIPOSOMAL BUPIVACAINE MARKET, KEY COMPANY PROFILES
12.1. SUN PHARMACEUTICAL INDUSTRIES LTD.
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. JOHNSON AND JOHNSON
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. MERCK AND CO.
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. CIPLA, INC.
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. CADILA PHARMACEUTICALS
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. SRS PHARMACEUTICALS PVT. LTD.
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. EXPAREL
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. PACIRA
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS


* Above given report scope is tentative, and may change during the study process as per the research requirement.
* List of companies provided under ‘Company Profile’ chapter is tentative and may change during the course of the study. This list is customizable as per the client requirements.
* Financial information would be provided only for the public companies.
The List of Companies

1. Sun Pharmaceutical Industries Ltd.
2. Johnson and Johnson
3. Merck and Co.
4. Cipla, Inc.
5. Cadila Pharmaceuticals
6. SRS Pharmaceuticals Pvt. Ltd.
7. EXPAREL
8. Pacira
TIPRE00022324
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking